Prostaglandin antagonism and antianaphylactic drug activity.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D002199:Capillary Permeability / Q000187:drug effects; D003374:Coumarins / Q000494:pharmacology*; D004205:Cromolyn Sodium / Q000494:pharmacology; D003594:Cytoplasmic Granules / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D000882:Haplorhini; D006636:Histamine Release / Q000187:drug effects; D008407:Mast Cells / Q000276:immunology; D008784:Methysergide / Q000494:pharmacology; D010323:Passive Cutaneous Anaphylaxis; D010879:Piperazines / Q000494:pharmacology*; D011458:Prostaglandins E / Q000037:antagonists & inhibitors*; D051381:Rats; D012702:Serotonin Antagonists; D012882:Skin Tests
D000893:Anti-Inflammatory Agents; D003374:Coumarins; D010879:Piperazines; D011458:Prostaglandins E; D012702:Serotonin Antagonists; D004205:Cromolyn Sodium; D008784:Methysergide